Safety and Effectiveness of the Calhoun Vision Light Adjustable Intraocular Lens (LAL)

Exclusion Criteria

• •Zonular laxity or dehiscence.
• •Pseudoexfoliation.
• •Age related macular degeneration involving the presence of geographic atrophy or soft drusen.
• •Retinal degenerative disorder that is expected to cause future vision loss.
• •Diabetes with any evidence of retinopathy.
• •Evidence of glaucomatous optic neuropathy.
• •History of uveitis.
• •Significant anterior segment pathology, such as rubeosis iridis, aniridia, or iris coloboma.
• •Corneal pathology that is either progressive or sufficient to reduce BCVA to 20/25 or worse.
• •Keratoconus or suspected of having keratoconus.
• •Corneal dystrophy including basement membrane dystrophy.
• •Previous corneal or intraocular surgery
• •Systemic medication that may increase sensitivity to UV light such as tetracycline, doxycycline, psoralens, amiodarone, and phenothiazines.
• •Complications during cataract surgery including posterior capsule rupture, zonular rupture, radial capsulorhexis tear, vitreous loss, iris trauma, corneal complications or any intraoperative abnormality that may affect the postoperative pupillary dilation, or the centration or tilt of the intraocular lens.